Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-1.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -15.10% |
| Q3 2025 | 18.49% |
| Q2 2025 | 1.84% |
| Q1 2025 | 31.41% |
| Q4 2024 | -5.75% |
| Q3 2024 | 10.76% |
| Q2 2024 | -27.04% |
| Q1 2024 | 23.26% |
| Q4 2023 | 12.40% |
| Q3 2023 | -46.61% |
| Q2 2023 | 21.25% |
| Q1 2023 | 1.32% |
| Q4 2022 | -3.22% |
| Q3 2022 | 40.71% |
| Q2 2022 | -14.45% |
| Q1 2022 | -22.88% |
| Q4 2021 | 10.17% |
| Q3 2021 | -19.20% |
| Q2 2021 | 15.41% |
| Q1 2021 | 2420.54% |
| Q4 2020 | -44.47% |
| Q3 2020 | -4.47% |
| Q2 2020 | -59.86% |
| Q1 2020 | 684.32% |
| Q4 2019 | 61.89% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 1.96% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | -99.80% |